Aethlon Medical Inc (NAS:AEMD)
$ 0.5859 0.0358 (6.51%) Market Cap: 2.98 Mil Enterprise Value: -3.99 Mil PE Ratio: 0 PB Ratio: 0.20 GF Score: 51/100

Aethlon Medical Inc at HC Wainwright Investment Conference - New York Transcript

Sep 12, 2023 / 08:30PM GMT
Release Date Price: $2.73
Vernon Bernardino
H.C. Wainwright & Co., LLC - Analyst

Hi, everyone. Welcome to the second day of the H.C. Wainwright 25th Annual Global Investment Conference. My name is Vernon Bernardino, a senior analyst. With us today, our next company is Aethlon Medical, which I think would be very interested in because with the Hemopurifier, I think it's a novel approach to treating diseases, particularly in the COVID space. There's a real opportunity there.

I don't think anyone would have thought of, but they've established a track record with other viruses. And I think you'll be interested in what they had to say there. But also in oncology in that space, something called (technical difficulty).

With us today is the Chief Medical Officer, Steven LaRosa; and the Chief Financial Officer, Jim Frakes. Take it away, Jim.

Jim Frakes
Aethlon Medical, Inc. - CFO & SVP, Finance

Thank you, Vernon. And thanks, everybody, for attending our presentation. Forward-looking statement, you can look at that your convenience. Our presentation will be on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot